CANDIDO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 9.930
AS - Asia 6.383
EU - Europa 4.443
SA - Sud America 903
Continente sconosciuto - Info sul continente non disponibili 493
AF - Africa 189
OC - Oceania 41
Totale 22.382
Nazione #
US - Stati Uniti d'America 9.636
SG - Singapore 2.051
CN - Cina 1.362
IT - Italia 1.183
HK - Hong Kong 736
PL - Polonia 712
BR - Brasile 653
KR - Corea 555
VN - Vietnam 543
SE - Svezia 435
BD - Bangladesh 321
UA - Ucraina 317
FR - Francia 303
FI - Finlandia 264
DE - Germania 243
GB - Regno Unito 226
NL - Olanda 186
IN - India 181
RU - Federazione Russa 173
TR - Turchia 136
CA - Canada 118
MX - Messico 96
BG - Bulgaria 73
MA - Marocco 71
AR - Argentina 68
JP - Giappone 67
IE - Irlanda 64
ID - Indonesia 62
ES - Italia 58
CO - Colombia 45
EC - Ecuador 43
PK - Pakistan 43
PH - Filippine 39
AT - Austria 38
IQ - Iraq 34
TW - Taiwan 33
AU - Australia 32
PE - Perù 30
ZA - Sudafrica 28
CH - Svizzera 25
EG - Egitto 25
BE - Belgio 23
IL - Israele 23
SA - Arabia Saudita 23
CL - Cile 22
TH - Thailandia 20
IR - Iran 18
NP - Nepal 17
HR - Croazia 16
TN - Tunisia 16
CZ - Repubblica Ceca 15
PY - Paraguay 15
VE - Venezuela 15
MY - Malesia 14
SN - Senegal 14
AZ - Azerbaigian 13
GR - Grecia 13
LB - Libano 13
JM - Giamaica 12
JO - Giordania 12
UZ - Uzbekistan 12
CR - Costa Rica 11
DK - Danimarca 11
NI - Nicaragua 11
EU - Europa 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
RS - Serbia 8
DZ - Algeria 7
HN - Honduras 7
KE - Kenya 7
KZ - Kazakistan 7
RO - Romania 7
SV - El Salvador 7
AL - Albania 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
LT - Lituania 6
MM - Myanmar 6
CY - Cipro 5
UY - Uruguay 5
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
LU - Lussemburgo 4
PA - Panama 4
PS - Palestinian Territory 4
AM - Armenia 3
BB - Barbados 3
EE - Estonia 3
GT - Guatemala 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
Totale 21.856
Città #
Singapore 1.170
Ashburn 1.097
San Jose 750
Hong Kong 723
Woodbridge 700
Ann Arbor 624
Warsaw 593
Houston 591
Fairfield 528
Seoul 527
Council Bluffs 491
Chandler 412
Hefei 361
Boardman 294
Seattle 269
Jacksonville 264
Beijing 262
Wilmington 246
Ho Chi Minh City 183
Cambridge 176
Columbus 170
Los Angeles 169
Milan 163
Trieste 151
Chicago 142
Helsinki 139
Hanoi 125
Dallas 116
New York 100
Princeton 100
Lauterbourg 99
Santa Clara 98
Zgierz 98
The Dalles 93
Izmir 90
Moscow 77
Buffalo 74
London 74
Frankfurt am Main 69
Rome 67
São Paulo 67
Phoenix 65
Casablanca 63
Sofia 62
Dublin 58
Tokyo 45
Shanghai 44
Düsseldorf 41
Nuremberg 41
Dearborn 40
Orem 40
Munich 37
Atlanta 33
Boston 32
San Diego 32
Chennai 31
Montreal 28
Toronto 28
Mumbai 27
Brooklyn 26
Washington 26
Memphis 24
Naples 24
Brussels 23
Guangzhou 23
Haiphong 23
Jinan 23
San Francisco 23
Denver 22
Miano 22
Rio de Janeiro 22
Hangzhou 21
Manchester 21
Zhengzhou 21
Dhaka 20
Stockholm 20
Chengdu 19
Florence 19
North Bergen 19
Redondo Beach 19
Bari 18
Da Nang 18
Lappeenranta 18
Turku 18
Baghdad 17
Mexico City 17
Venice 17
Verona 17
Vienna 17
Cairo 16
Istanbul 15
Manila 15
Pune 15
Quito 15
Salt Lake City 15
Santiago 15
Amsterdam 14
Brasília 14
Falls Church 14
Guayaquil 14
Totale 14.068
Nome #
A new ultrasonographic instrument for measuring vessel wall shear stress. 488
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 431
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 422
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events 391
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 377
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 353
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 316
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. 310
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 305
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 279
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 277
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 275
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 269
Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 260
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 256
ACE2 deficiency shifts energy metabolism towards glucose utilization 256
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 254
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 240
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 235
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 234
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 232
Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm 231
TRAIL shows potential cardioprotective activity. 226
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 224
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 222
Italian guidelines for the treatment of type 2 diabetes 215
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 214
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 212
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 211
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 211
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 206
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension 205
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 191
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 189
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 189
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB 188
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents 186
Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: a retrospective cohort study 185
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 185
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 184
Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group 183
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 183
Angiotensin II promotes apoptosis in ventricular cardiomyoctes in vivo 179
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 177
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 171
Modulation of cardiac apoptosis by estrogen and ACE inhibition in ovariectomized spontaneously hypertensive rats 171
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 167
Italian guidelines for the treatment of type 2 diabetes 167
Regional and systemic haemodynamic response to aortography in hypertensives. 160
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 157
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study 156
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 153
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study 152
Endothelium vasomotor function after LDL-apheresis in patients with familial hypercolesterolemia 152
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. 151
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression 151
Linking diabetes and atherosclerosis 150
Retrospective cohort study on treatment outcomes of early vs late onset gestational diabetes mellitus 146
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells 144
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice 138
Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years 137
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience 136
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 131
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 131
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 130
Treatment for diabetic nephropathy - a review of the recent patent literature 130
Personalized Approach for the Management of Exercise-Related Glycemic Imbalances in Type 1 Diabetes: Comparison with Reference Method 130
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes 129
Large artery mechanics after bladder neck obstruction in SHR rats 128
Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes 127
The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals initiative 127
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 126
A review of the latest real‐world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions? 125
Modulation of glomerular albumin permeability by angiotensin II infusion and effects of angiotensin type 1 receptor blockade 123
Tips for successful use of commercial automated insulin delivery systems: An expert paper of the Italian working group on diabetes and technology 122
2023 update on Italian guidelines for the treatment of type 2 diabetes 119
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti 117
A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy 114
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative 113
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies 111
Type 2 diabetes specialist care in Italy in the AMD Annals initiative 2024: The path is traced 110
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes 110
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care 109
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products 107
Sinergia collaborativa nella gestione del paziente diabetico con recente sindrome coronarica acuta 107
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 106
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database 105
Socioeconomic and health disparities in adults diagnosed with type 1 diabetes mellitus before age 18: insights from the Italian PASSI surveillance system 103
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 103
Open questions on basal insulin therapy in T2D: a Delphi consensus 103
Prevalence and clinical determinants of rapid eGFR decline among patients with newly diagnosed type 2 diabetes 102
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 102
Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk 101
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 101
Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform 98
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 98
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications 97
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group 93
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 92
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study 89
Totale 18.084
Categoria #
all - tutte 67.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022571 0 0 24 58 21 57 32 17 71 67 54 170
2022/20231.120 87 126 99 146 113 207 3 108 155 15 46 15
2023/20241.332 47 233 74 57 109 86 201 148 23 27 157 170
2024/20253.585 128 125 206 240 527 464 305 203 389 434 261 303
2025/20268.740 636 568 570 839 610 704 1.010 363 984 1.332 646 478
2026/20271.936 691 691 554 0 0 0 0 0 0 0 0 0
Totale 22.382